Group One Trading’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,300
| Closed | -$430 | – | 7582 |
|
|
2025
Q4 | $430 | Sell |
4,300
-42,800
| -91% | -$27.2K | ﹤0.01% | 7825 |
|
|
2025
Q3 | $28.5K | Buy |
47,100
+13,000
| +38% | +$6.12K | ﹤0.01% | 6415 |
|
|
2025
Q2 | $10.6K | Buy |
34,100
+1,100
| +3% | +$426 | ﹤0.01% | 6682 |
|
|
2025
Q1 | $16.1K | Sell |
33,000
-267,900
| -89% | -$158K | ﹤0.01% | 5959 |
|
|
2024
Q4 | $258K | Buy |
300,900
+243,300
| +422% | +$1.53M | ﹤0.01% | 3738 |
|
|
2024
Q3 | $490K | Buy |
57,600
+56,100
| +3,740% | +$331K | ﹤0.01% | 2868 |
|
|
2024
Q2 | $7K | Sell |
1,500
-1,300
| -46% | -$6.15K | ﹤0.01% | 5806 |
|
|
2024
Q1 | $19K | Buy |
2,800
+1,600
| +133% | +$7.18K | ﹤0.01% | 5455 |
|
|
2023
Q4 | $4.02K | Buy |
1,200
+1,100
| +1,100% | +$2.74K | ﹤0.01% | 6591 |
|
|
2023
Q3 | $249 | Buy |
+100
| New | +$165 | ﹤0.01% | 7418 |
|
|
2022
Q1 | – | Sell |
-100
| Closed | -$1K | – | 7977 |
|
|
2021
Q4 | $1K | Sell |
100
-2,500
| -96% | -$32.8K | ﹤0.01% | 7959 |
|
|
2021
Q3 | $43K | Buy |
2,600
+600
| +30% | +$10.4K | ﹤0.01% | 6655 |
|
|
2021
Q2 | $42K | Buy |
+2,000
| New | +$37.9K | ﹤0.01% | 6716 |
|
Group One Trading's APLT Position: Q1 2026 in Review
Group One Trading sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 48,675 shares — an estimated $4.87K sold.
Group One Trading first reported a position in APLT in Q1 2021 and held it in 17 quarters. The position peaked at $1.36M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Group One Trading reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 48,675 Applied Therapeutics shares in Q1 2026, an estimated $4.87K.
- Group One Trading first reported a position in Applied Therapeutics in Q1 2021 and held it in 17 quarters.
- Group One Trading's Applied Therapeutics position peaked at $1.36M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.